AR103555A1 - Composiciones y métodos para el uso crónico de un compuesto para aumentar el peso - Google Patents
Composiciones y métodos para el uso crónico de un compuesto para aumentar el pesoInfo
- Publication number
- AR103555A1 AR103555A1 ARP160100245A ARP160100245A AR103555A1 AR 103555 A1 AR103555 A1 AR 103555A1 AR P160100245 A ARP160100245 A AR P160100245A AR P160100245 A ARP160100245 A AR P160100245A AR 103555 A1 AR103555 A1 AR 103555A1
- Authority
- AR
- Argentina
- Prior art keywords
- compositions
- compound
- methods
- livestock
- increase weight
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 230000001684 chronic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000796 flavoring agent Substances 0.000 abstract 3
- 244000144972 livestock Species 0.000 abstract 3
- KVLLHLWBPNCVNR-SKCUWOTOSA-N capromorelin Chemical compound C([C@@]12CN(CCC1=NN(C2=O)C)C(=O)[C@@H](COCC=1C=CC=CC=1)NC(=O)C(C)(C)N)C1=CC=CC=C1 KVLLHLWBPNCVNR-SKCUWOTOSA-N 0.000 abstract 2
- 229950004826 capromorelin Drugs 0.000 abstract 2
- 235000019634 flavors Nutrition 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 235000013355 food flavoring agent Nutrition 0.000 abstract 1
- 230000000873 masking effect Effects 0.000 abstract 1
- 208000016261 weight loss Diseases 0.000 abstract 1
- 230000004580 weight loss Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/132—Heterocyclic compounds containing only one nitrogen as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/184—Hormones
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/20—Feeding-stuffs specially adapted for particular animals for horses
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/61—Growth hormones [GH] (Somatotropin)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S426/00—Food or edible material: processes, compositions, and products
- Y10S426/805—Pet food for dog, cat, bird, or fish
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Birds (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
Abstract
Método para el tratamiento de la pérdida de peso en uno o más animales de compañía o ganado. El método puede incluir administrar una cantidad terapéuticamente efectiva de una composición que contiene capromorelina a un animal de compañía o ganado que lo necesita durante un período de por lo menos 30 días. Opcionalmente, se puede agregar uno o más agentes saborizantes o agentes enmascaradores del sabor a la composición que contiene capromorelina para mejorar o enmascarar el sabor de la composición para el animal de compañía o ganado.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562108902P | 2015-01-28 | 2015-01-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR103555A1 true AR103555A1 (es) | 2017-05-17 |
Family
ID=56433115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP160100245A AR103555A1 (es) | 2015-01-28 | 2016-01-28 | Composiciones y métodos para el uso crónico de un compuesto para aumentar el peso |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US9700591B2 (es) |
| EP (1) | EP3250203B1 (es) |
| JP (2) | JP6467513B2 (es) |
| KR (3) | KR20180108916A (es) |
| CN (2) | CN109200268A (es) |
| AR (1) | AR103555A1 (es) |
| AU (1) | AU2016211520B2 (es) |
| BR (1) | BR112017016078A2 (es) |
| CA (1) | CA2974012C (es) |
| ES (1) | ES2902795T3 (es) |
| FR (1) | FR23C1045I2 (es) |
| MX (1) | MX383741B (es) |
| NL (1) | NL301251I2 (es) |
| NO (1) | NO2023044I1 (es) |
| NZ (1) | NZ733658A (es) |
| PL (1) | PL3250203T3 (es) |
| PT (1) | PT3250203T (es) |
| RU (1) | RU2680410C1 (es) |
| TW (2) | TWI674896B (es) |
| WO (1) | WO2016123233A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7105232B2 (ja) * | 2016-11-11 | 2022-07-22 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | ペットフードの組成物及び方法 |
| US11432776B2 (en) * | 2019-06-13 | 2022-09-06 | International Business Machines Corporation | Medical device administration and interaction |
| WO2024173199A1 (en) * | 2023-02-13 | 2024-08-22 | Myos Corp. | Treatment for chronic kidney disease |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2095786A1 (en) | 1992-05-08 | 1993-11-09 | Franco J. Vaccarino | Method of stimulating appetite |
| EP1181933A3 (en) | 2000-06-29 | 2002-04-10 | Pfizer Products Inc. | Use of growth hormone secretagogues for stimulating or increasing appetite |
| US8309603B2 (en) | 2004-06-07 | 2012-11-13 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
| US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
| US7491695B2 (en) * | 2003-06-18 | 2009-02-17 | Tranzyme Pharma Inc. | Methods of using macrocyclic modulators of the ghrelin receptor |
| BRPI0618222A2 (pt) | 2005-11-02 | 2011-08-23 | Nestec Sa | composições de isoflavona para reduzir o acúmulo de gordura corporal em animais machos, e métodos para seu uso |
| NZ576470A (en) | 2006-09-27 | 2012-09-28 | Ipsen Pharma Sas | Analogs of ghrelin substituted at the n-terminal |
| ES2604943T3 (es) * | 2007-02-09 | 2017-03-10 | Ocera Therapeutics, Inc. | Moduladores macrocíclicos del receptor de la grelina y procedimientos de uso de los mismos |
| TWI429436B (zh) | 2007-04-10 | 2014-03-11 | Helsinn Therapeutics Us Inc | 使用生長激素促泌素治療或預防嘔吐之方法 |
| RU2007129408A (ru) | 2007-07-31 | 2009-02-10 | Игорь Николаевич Жирков (RU) | Способ выращивания поросят в период откорма |
| FR2920295B1 (fr) | 2007-09-05 | 2009-12-11 | Desvac | Dispositif d'injection de produits veterinaires a des volailles, comprenant un element de contention presentant une forme anatomique incluant des moyens de calage d'un os reperable |
| GEP20156222B (en) | 2009-03-26 | 2015-01-26 | Takeda Pharmaceutical | Pyrazole compound |
| CA2789750C (en) * | 2010-02-26 | 2018-03-06 | Raqualia Pharma Inc. | Ghrelin receptor agonist for treatment of cachexia |
| EP3524260B1 (en) * | 2012-09-27 | 2023-09-13 | Elanco Animal Health Incorporated | Pharmaceutical compositions for treatment of inappetence |
| ES2703523T3 (es) * | 2013-03-15 | 2019-03-11 | Mars Inc | Tratamiento de emesis idiopática crónica en felinos y cánidos |
-
2016
- 2016-01-27 KR KR1020187027818A patent/KR20180108916A/ko not_active Ceased
- 2016-01-27 US US15/007,525 patent/US9700591B2/en active Active
- 2016-01-27 KR KR1020187035176A patent/KR102256847B1/ko active Active
- 2016-01-27 ES ES16744044T patent/ES2902795T3/es active Active
- 2016-01-27 BR BR112017016078A patent/BR112017016078A2/pt not_active Application Discontinuation
- 2016-01-27 EP EP16744044.5A patent/EP3250203B1/en active Active
- 2016-01-27 NZ NZ733658A patent/NZ733658A/en unknown
- 2016-01-27 JP JP2017540234A patent/JP6467513B2/ja active Active
- 2016-01-27 PL PL16744044T patent/PL3250203T3/pl unknown
- 2016-01-27 AU AU2016211520A patent/AU2016211520B2/en active Active
- 2016-01-27 MX MX2017009435A patent/MX383741B/es unknown
- 2016-01-27 RU RU2017128087A patent/RU2680410C1/ru active
- 2016-01-27 WO PCT/US2016/015150 patent/WO2016123233A1/en not_active Ceased
- 2016-01-27 CA CA2974012A patent/CA2974012C/en active Active
- 2016-01-27 PT PT167440445T patent/PT3250203T/pt unknown
- 2016-01-27 KR KR1020177021599A patent/KR20170097212A/ko not_active Ceased
- 2016-01-27 CN CN201811346148.5A patent/CN109200268A/zh active Pending
- 2016-01-27 CN CN201680007537.8A patent/CN107205991A/zh active Pending
- 2016-01-28 TW TW105102744A patent/TWI674896B/zh active
- 2016-01-28 AR ARP160100245A patent/AR103555A1/es unknown
- 2016-01-28 TW TW107115943A patent/TWI731241B/zh active
-
2017
- 2017-05-22 US US15/601,240 patent/US10064909B2/en active Active
-
2018
- 2018-10-12 JP JP2018193722A patent/JP7120718B2/ja active Active
-
2023
- 2023-11-21 NL NL301251C patent/NL301251I2/nl unknown
- 2023-11-28 FR FR23C1045C patent/FR23C1045I2/fr active Active
- 2023-12-05 NO NO2023044C patent/NO2023044I1/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2018001753A1 (es) | Composiciones para modular la expresión de c9orf72 (divisional solicitud 201600839) | |
| SV2017005461A (es) | Benzamidas sustituidas con 1,3-tiazol-2-ilo | |
| MX2016002077A (es) | Inhibidores de la proteína regulada por glucosa 94 (gpr94) selectivos y usos de los mismos. | |
| CL2017002936A1 (es) | Compuestos ciclooctadepsipéptidos, composición veterinaria antihelmíntica, y uso para preparar un medicamento útil contra infección por parásitos o una infestación por parásitos internos o externos en un animal. | |
| CL2015002677A1 (es) | Composiciones que comprenden selenio y uso de las mismas para el tratamiento y prevención de enfermedades o condiciones asociadas con la disfunción mitocondrial. | |
| MX376210B (es) | Uso de derivados de isoxazolina para el tratamiento o prevención de infestaciones por artrópodos en aves de corral. | |
| BRPI0911031B8 (pt) | compostos de piperidina ligada do tipo quinoxalina substituídos e os usos destes | |
| MX2018003893A (es) | Moduladores del receptor p2x3 y p2x2/3 de diaminopirimidina para usarse en el tratamiento de la tos. | |
| MX2019006893A (es) | Inhibidores heterociclicos de mct4. | |
| MX2022015141A (es) | Composiciones y metodos de uso de un compuesto de control de inapetencia. | |
| CL2019003670A1 (es) | Composición que comprende manosa oligosacárido y proceso para realizarla y uso de esta. | |
| BR112017000520A2 (pt) | composto ou sal do mesmo, uso um composto ou de um sal, e, kit. | |
| PE20191149A1 (es) | Uso farmaceutico de una composicion que contiene pirfenidona de liberacion prolongada (pfd-lp) para la reversion y tratamiento de la esteatohepatitis humana (nafld/nash) | |
| MX2016015437A (es) | Combinacion que comprende un glucocorticoide y edo-s101. | |
| ZA201904591B (en) | Dexmedetomidine or medetomidine for use in treating separation anxiety in dogs | |
| CL2015003663A1 (es) | Compuestos de pirimidinio sustituidos y derivados para combatir plagas animales. | |
| AR103555A1 (es) | Composiciones y métodos para el uso crónico de un compuesto para aumentar el peso | |
| ECSP17031291A (es) | Composición para el tratamiento de ectoparasitosis y la promoción del crecimiento en acuicultura | |
| MX2020010243A (es) | Composiciones bucales y metodos para animales. | |
| EA201590097A1 (ru) | Составы с однократной дозой для перорального введения и способы лечения кошек с помощью спиносада, уничтожающего эктопаразитов | |
| AR104184A1 (es) | Composición pesticida que comprende metomilo y lufenuron | |
| MX2018004532A (es) | Combinacion de trazodona y gabapentina para el tratamiento de dolor. | |
| GB2550750A (en) | Anthelmintic compounds | |
| CL2019001924A1 (es) | Composición fungicida efectiva contra alternaria en cítricos. (divisional solicitud 201701815) | |
| AR103768A1 (es) | Composiciones para uso en el tratamiento de diarrea y en la promoción de la salud intestinal en animales no humanos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |